Rev1 Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Nexosome Oncology HoldingsNov 2021SEC filingmedium confidence
HealthtechLexington, US
Alan Ezrin(Director)Todd Hembrough(Executive Officer, Director)Robert Saunders(Director)Matthew Dicken(Director)
Board seatBrian Brohman· per SEC Form D · $4M raise · filed Nov 2021
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.